108 related articles for article (PubMed ID: 21370430)
21. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
22. New targets for Ph+ leukaemia therapy.
Martinelli G; Iacobucci I; Papayannidis C; Soverini S
Best Pract Res Clin Haematol; 2009 Sep; 22(3):445-54. PubMed ID: 19959093
[TBL] [Abstract][Full Text] [Related]
23. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
[TBL] [Abstract][Full Text] [Related]
25. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
27. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
29. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
Chen IM; Harvey RC; Mullighan CG; Gastier-Foster J; Wharton W; Kang H; Borowitz MJ; Camitta BM; Carroll AJ; Devidas M; Pullen DJ; Payne-Turner D; Tasian SK; Reshmi S; Cottrell CE; Reaman GH; Bowman WP; Carroll WL; Loh ML; Winick NJ; Hunger SP; Willman CL
Blood; 2012 Apr; 119(15):3512-22. PubMed ID: 22368272
[TBL] [Abstract][Full Text] [Related]
30. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
[TBL] [Abstract][Full Text] [Related]
31. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.
Mullighan CG; Downing JR
Leukemia; 2009 Jul; 23(7):1209-18. PubMed ID: 19242497
[TBL] [Abstract][Full Text] [Related]
33. Advances in acute lymphoblastic leukemia in adults.
Ribera JM
Curr Opin Oncol; 2011 Nov; 23(6):692-9. PubMed ID: 21892082
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.
Loh ML; Zhang J; Harvey RC; Roberts K; Payne-Turner D; Kang H; Wu G; Chen X; Becksfort J; Edmonson M; Buetow KH; Carroll WL; Chen IM; Wood B; Borowitz MJ; Devidas M; Gerhard DS; Bowman P; Larsen E; Winick N; Raetz E; Smith M; Downing JR; Willman CL; Mullighan CG; Hunger SP
Blood; 2013 Jan; 121(3):485-8. PubMed ID: 23212523
[TBL] [Abstract][Full Text] [Related]
35. Novel agents and biomarkers for acute lymphoid leukemia.
Zhao Y; Huang H; Wei G
J Hematol Oncol; 2013 Jun; 6():40. PubMed ID: 23773228
[TBL] [Abstract][Full Text] [Related]
36. Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.
Tasian SK; Loh ML
Crit Rev Oncog; 2011; 16(1-2):13-24. PubMed ID: 22150304
[TBL] [Abstract][Full Text] [Related]
37. Lymphoid malignancies: Another face to the Janus kinases.
Scott LM
Blood Rev; 2013 Mar; 27(2):63-70. PubMed ID: 23340138
[TBL] [Abstract][Full Text] [Related]
38. The genomic landscape of acute lymphoblastic leukemia in children and young adults.
Mullighan CG
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):174-80. PubMed ID: 25696852
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of the leukemogenic mechanism of Ph-like acute lymphocytic leukemia for the identification of a novel therapeutic target].
Imamura T
Rinsho Ketsueki; 2021; 62(8):1131-1138. PubMed ID: 34497200
[TBL] [Abstract][Full Text] [Related]
40. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine.
Hunger SP; Mullighan CG
Blood; 2015 Jun; 125(26):3977-87. PubMed ID: 25999453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]